Key facts
- This page summarizes Dave Hoffmann's Form 4 filing for Molecular Templates, Inc..
- 1 reported transaction and 1 derivative row are listed below.
- Accepted by SEC: 30 Sep 2024, 17:36.
Dave Hoffmann - 27 Sep 2024 Form 4 Insider Report for Molecular Templates, Inc.
- Reporting relationship
- Director
- Issuer ticker
- N/A
- Reported as of
- 27 Sep 2024
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 30 Sep 2024, 17:36:32 UTC
- Prior SEC filing
- 31 Oct 2023
- Source filing
- View source filing
- Reporting owner signature
- /s/Dave Hoffman
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
Dave Hoffmann filed Form 4 for Molecular Templates, Inc. on 30 Sep 2024.
Change
- Previous filing in this sequence was filed on 31 Oct 2023.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
MTEM
transaction
Derivative
Stock Option (right to buy)
Award
- Transaction value
- $0
- Shares
- +1,000
- Change %
- Price
- $0.000000
- Shares after
- 1,000
- Date
- 27 Sep 2024
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 1,000
- Exercise price
- $1.41
- Footnotes
- F1
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 1 footnote
Footnote F1
The shares of common stock exercisable pursuant to the option will vest in full upon completion of continuous service for the Issuer on the first anniversary of the vesting commencement date of September 27, 2024.